The impact of polycystic ovary syndrome on placental histopathology patterns in in-vitro fertilization singleton live births.

[1]  J. Alijotas-Reig,et al.  Chronic Villitis of unknown etiology (VUE): Obstetrical features, outcome and treatment. , 2021, Journal of reproductive immunology.

[2]  D. Schust,et al.  Placental structural abnormalities in gestational diabetes and when they develop: A scoping review. , 2021, Placenta.

[3]  L. Giudice,et al.  Endometrial function in women with polycystic ovary syndrome: a comprehensive review. , 2020, Human reproduction update.

[4]  G. Desoye,et al.  Diabetes Mellitus, Obesity, and the Placenta. , 2020, Obstetrics and gynecology clinics of North America.

[5]  V. Padmanabhan,et al.  A narrative review of placental contribution to adverse pregnancy outcomes in women with polycystic ovary syndrome. , 2019, The Journal of clinical endocrinology and metabolism.

[6]  L. Moran,et al.  Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity—A systematic review, meta‐analysis, and meta‐regression , 2019, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[7]  G. Reaven,et al.  Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome , 2019, Endocrine.

[8]  G. Reaven,et al.  Relationship between surrogate estimates and direct measurement of insulin resistance in women with polycystic ovary syndrome , 2019, Journal of Endocrinological Investigation.

[9]  L. Redman,et al.  Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome†‡ , 2018, Human reproduction.

[10]  R. Redline,et al.  Fetal vascular malperfusion, an update , 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[11]  A. Heider.  Fetal Vascular Malperfusion. , 2017, Archives of pathology & laboratory medicine.

[12]  B. Tarlatzis,et al.  Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. , 2017, Metabolism: clinical and experimental.

[13]  G. Reaven,et al.  Cardiovascular disease in PCOS is related to severe insulin resistance, not mild. , 2017, Minerva Endocrinologica.

[14]  M. P. Koster,et al.  Increased rates of complications in singleton pregnancies of women previously diagnosed with polycystic ovary syndrome predominantly in the hyperandrogenic phenotype. , 2017, Fertility and sterility.

[15]  S. Palomba,et al.  Oocyte Competence in Women with Polycystic Ovary Syndrome , 2017, Trends in Endocrinology & Metabolism.

[16]  S. Palomba,et al.  Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review , 2016, Reproductive Biology and Endocrinology.

[17]  R. Azziz,et al.  Criteria, prevalence, and phenotypes of polycystic ovary syndrome. , 2016, Fertility and sterility.

[18]  Neil J Sebire,et al.  Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement. , 2016, Archives of pathology & laboratory medicine.

[19]  S. Jenkins-Jones,et al.  Contemporary Reproductive Outcomes for Patients With Polycystic Ovary Syndrome: A Retrospective Observational Study , 2016, The Journal of clinical endocrinology and metabolism.

[20]  B. Fauser,et al.  Placental characteristics in women with polycystic ovary syndrome. , 2015, Human reproduction.

[21]  B. Fauser,et al.  Pregnancy complications in women with polycystic ovary syndrome. , 2015, Human reproduction update.

[22]  F. Hirahara,et al.  Circumvallate Placenta: Associated Clinical Manifestations and Complications—A Retrospective Study , 2014, Obstetrics and gynecology international.

[23]  F. Zullo,et al.  Early trophoblast invasion and placentation in women with different PCOS phenotypes. , 2014, Reproductive biomedicine online.

[24]  Joselyn Rojas,et al.  Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth , 2014, International journal of reproductive medicine.

[25]  F. Zullo,et al.  Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome. , 2013, Human reproduction.

[26]  Mu-Jun Li,et al.  Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis , 2013, Reproductive Biology and Endocrinology.

[27]  F. Zullo,et al.  Decidual endovascular trophoblast invasion in women with polycystic ovary syndrome: an experimental case-control study. , 2012, The Journal of clinical endocrinology and metabolism.

[28]  N. Sebire,et al.  Frequency and clinical significance of placental histological lesions in an unselected population at or near term , 2011, Virchows Archiv.

[29]  L. Sanchez-Ramos,et al.  Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. , 2011, American journal of obstetrics and gynecology.

[30]  F. Orio,et al.  Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. , 2010, Fertility and sterility.

[31]  R. Viscardi,et al.  Discrepancy in pathologic diagnosis of placental lesions. , 2009, Archives of pathology & laboratory medicine.

[32]  S. Marinopoulos,et al.  Placental pathology in women with gestational diabetes , 2008, Acta obstetricia et gynecologica Scandinavica.

[33]  Z. Calay,et al.  The Incidence of Placental Abnormalities, Maternal and Cord Plasma Malondialdehyde and Vascular Endothelial Growth Factor Levels in Women with Gestational Diabetes Mellitus and Nondiabetic Controls , 2008, Gynecologic and Obstetric Investigation.

[34]  Shunji Suzuki.  Clinical significance of pregnancies with circumvallate placenta , 2007, The journal of obstetrics and gynaecology research.

[35]  A. Franx,et al.  Inflammatory Changes in Preeclampsia: Current Understanding of the Maternal Innate and Adaptive Immune Response , 2007, Obstetrical & gynecological survey.

[36]  Richard S Legro,et al.  Polycystic ovary syndrome , 2007, The Lancet.

[37]  M. Eijkemans,et al.  A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. , 2006, Human reproduction update.

[38]  R. Azziz.  How prevalent is metabolic syndrome in women with polycystic ovary syndrome? , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[39]  R. Azziz.  Diagnostic criteria for polycystic ovary syndrome: a reappraisal. , 2005, Fertility and sterility.

[40]  S. Palomba,et al.  Pregnancy complications in women with polycystic ovary syndrome: importance of diagnostic criteria or of phenotypic features? , 2016, Human reproduction.

[41]  C. Sibley,et al.  Obesity and the placenta: A consideration of nutrient exchange mechanisms in relation to aberrant fetal growth. , 2011, Placenta.

[42]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.